Selective tumor cell death induced by irradiated riboflavin through recognizing DNA G-T mismatch

Area of Science:

• Molecular Biology
• Biochemistry
• Photodynamic Therapy
• Cancer Research

Background:

• Riboflavin (vitamin B2) shows potential as an antitumoral agent in photodynamic therapy.
• The precise molecular mechanisms underlying riboflavin's anticancer effects have remained unclear.
• Photodynamic therapy applications are often limited by incomplete understanding of drug action.

Purpose of the Study:

• To elucidate the molecular mechanism of riboflavin's antitumoral activity.
• To investigate riboflavin's interaction with DNA and its effects under irradiation.
• To explore the potential of targeting G-T mismatches in cancer therapy.

Main Methods:

• Investigated riboflavin's DNA binding specificity.
• Assessed riboflavin's ability to induce DNA strand breaks upon photo-irradiation.
• Evaluated the selective killing of tumor cells with defective mismatch repair systems.

Main Results:

• Riboflavin specifically recognizes and binds to G-T mismatch DNA sequences.
• Photo-irradiation in the presence of riboflavin efficiently induces single-strand breaks in duplex DNA targets.
• Tumor cells deficient in mismatch repair systems undergo selective cell death under riboflavin photo-irradiation.

Conclusions:

• Riboflavin's mechanism involves specific G-T mismatch recognition and photo-induced DNA damage.
• G-T mismatches represent a viable drug target for selective tumor cell destruction.
• Riboflavin serves as a promising lead compound for developing novel anticancer drugs targeting DNA mismatches.